Perceptive Advisors LLC Rapt Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

$2.39 Billion
Q1 2025

A detailed history of Perceptive Advisors LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 4,418,947 shares of RAPT stock, worth $45.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

4,418,947

Previous 5,880,000 24.85%

Holding current value

$45.2 Million

Previous $9.29 Million 41.97%

% of portfolio

0.23%

Previous 0.31%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.05 - $1.72 $1.53 Million - $2.51 Million	-1,461,053 Reduced 24.85%	4,418,947 $5.39 Million
Q4 2024 Feb 14, 2025	BUY	$0.81 - $3.1 $4.76 Million - $18.2 Million	5,880,000 New	5,880,000 $9.29 Million
Q1 2024 May 15, 2024	SELL	$6.87 - $26.45 $6.3 Million - $24.2 Million	-916,478 Reduced 42.83%	1,223,472 $11 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $2.47 Million - $5.58 Million	219,292 Added 11.42%	2,139,950 $53.2 Million
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $6.01 Million - $9.07 Million	-367,835 Reduced 16.07%	1,920,658 $31.9 Million
Q2 2023 Aug 14, 2023	SELL	$16.06 - $21.61 $50,026 - $67,315	-3,115 Reduced 0.14%	2,288,493 $42.8 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $8.47 Million - $15.2 Million	492,653 Added 27.39%	2,291,608 $42.1 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $1.4 Million - $2.11 Million	85,821 Added 5.01%	1,798,955 $35.6 Million
Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $3.6 Million - $6.11 Million	-200,657 Reduced 10.48%	1,713,134 $41.2 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $9.09 Million - $20.9 Million	-886,171 Reduced 31.65%	1,913,791 $34.9 Million
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $2.17 Million - $5.13 Million	-127,603 Reduced 4.36%	2,799,962 $61.6 Million
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $590,000 - $790,000	20,000 Added 0.69%	2,927,565 $108 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $12.9 Million - $17 Million	431,905 Added 17.45%	2,907,565 $90.3 Million
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $32,759 - $72,876	-1,821 Reduced 0.07%	2,475,660 $78.7 Million
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $14.4 Million - $22 Million	900,000 Added 57.05%	2,477,481 $55 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $25.1 Million - $64.5 Million	1,577,481 New	1,577,481 $31.2 Million

Others Institutions Holding RAPT

# of Institutions

Shares Held

111M

Call Options Held

41.3K

Put Options Held

100

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $303M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Rapt Therapeutics, Inc. Transaction History